CryoLife to Present at Sidoti's 13th Annual New York Emerging Growth Institutional Forum
March 19 2009 - 8:30AM
PR Newswire (US)
ATLANTA, March 19 /PRNewswire-FirstCall/ -- CryoLife, Inc.
(NYSE:CRY), an implantable biological medical device and tissue
processing company, announced today that it will participate in the
Sidoti & Company, LLC 13th Annual New York Emerging Growth
Institutional Forum at The Grand Hyatt Hotel on Wednesday, March
25, 2009. D. Ashley Lee, executive vice president, chief operating
officer and chief financial officer of CryoLife, Inc., will present
a corporate overview at 2:05 p.m. Eastern Time. A copy of
CryoLife's slide presentation will be posted the day of the
presentation on the Investor Relations page of
http://www.cryolife.com/. About CryoLife Founded in 1984, CryoLife,
Inc. is a leader in the processing and distribution of implantable
living human tissues for use in cardiac and vascular surgeries
throughout the U.S. and Canada. The Company received FDA clearance
for the CryoValve(R) SG pulmonary human heart valve, processed
using CryoLife's proprietary SynerGraft(R) Technology. The
Company's BioGlue(R) Surgical Adhesive is FDA approved as an
adjunct to sutures and staples for use in adult patients in open
surgical repair of large vessels. BioGlue is also CE marked in the
European Community and approved in Canada and Australia for use in
soft tissue repair. CryoLife distributes Hemostase MPH, a
hemostatic agent, in much of the U.S. for use in cardiac and
vascular surgery and in the United Kingdom, Germany, France, and
Canada for cardiac, vascular, and general surgery, subject to
certain exclusions. For additional information about the Company,
visit CryoLife's Web Site: http://www.cryolife.com/. Media
Contacts: D. Ashley Lee Katie Brazel Executive Vice President,
Chief Financial Officer and Fleishman Hillard Chief Operating
Officer Phone: 404-739-0150 Phone: 770-419-3355 DATASOURCE:
CryoLife, Inc. CONTACT: D. Ashley Lee, Executive Vice President,
Chief Financial Officer and Chief Operating Officer of CryoLife,
Inc., +1-770-419-3355; Katie Brazel of Fleishman Hillard,
+1-404-739-0150, for CryoLife, Inc. Web Site:
http://www.cryolife.com/
Copyright
CryoLife (NYSE:CRY)
Historical Stock Chart
From Jun 2024 to Jul 2024
CryoLife (NYSE:CRY)
Historical Stock Chart
From Jul 2023 to Jul 2024